Lynda D. Roman

ORCID: 0000-0002-6960-4414 · 10 papers in corpus
2023
Clinical cancer research : an official journal of the American Association for Cancer Research ·doi:10.1158/1078-0432.ccr-23-1197

PurposeHigh-grade serous ovarian carcinoma (HGSOC) is the most lethal epithelial ovarian cancer (EOC) and is often diagnosed at late stage. In women with a known pelvic mass, surgery followed by pathologic assessment is the most reliable wa…

article 2022
·doi:10.1016/j.fertnstert.2022.08.670
other 2020
Journal of Minimally Invasive Gynecology ·doi:10.1016/j.jmig.2019.11.004

STUDY OBJECTIVE: The findings of previous studies have been inconsistent as to whether benign hysterectomy via minimally invasive laparoscopic surgery increases the risk of vesicoureteral injury when compared with laparotomy. The objectives…

article 2017
Archives of gynecology and obstetrics ·doi:10.1007/s00404-017-4375-z

PurposeWhile adenomyosis is one of the most common benign histologic findings in hysterectomy specimens of endometrial cancer, demographics of endometrial cancer arising in adenomyosis (EC-AIA) has not been well elucidated. The aim of this …

article 2016
·doi:10.1016/j.ygyno.2016.04.202
article 2015
·doi:10.1371/journal.pone.0130909

BACKGROUND: The molecular biology and cellular origins of mixed type endometrial carcinomas (MT-ECs) are poorly understood, and a Type II component of 10 percent or less may confer poorer prognoses. METHODOLOGY/PRINCIPAL FINDINGS: We studie…

article 2015
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology ·doi:10.1158/1055-9965.epi-14-1128

BACKGROUND: In U.S. women, lifetime risk of ovarian cancer is 1.37%, but some women are at a substantially lower or higher risk than this average. METHODS: We have characterized the distribution of lifetime risk in the general population. P…

article 2015
Annals of surgical oncology ·doi:10.1245/s10434-015-4952-y

BackgroundEndometrial cancer arising in adenomyosis (EC-AIA) is a rare entity of endometrial cancer, and its clinical significance has not been well studied. This study aimed to examine the tumor characteristics and survival outcomes of EC-…

article 2014
Annals of surgical oncology ·doi:10.1245/s10434-014-3880-6

BackgroundTo examine the effects of adenomyosis on tumor progression and survival outcome of endometrial cancer patients.MethodsThis is a retrospective study examining stage I-IV endometrial cancer patients who underwent hysterectomy-based …

article 2014
·doi:10.1016/j.jmig.2014.08.241